Rovadicitinib: Clinical Trials

1 trial of Rovadicitinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Rovadicitinib: new trials by email Literature Review of Rovadicitinib trials Research Report on Rovadicitinib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
Rovadicitinib, Imatinib, Methotrexate - Graft-versus-host Disease
Phase 3RecruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.1822024-11-202025-12-08

Conditions studied

Graft vs Host Disease (1)

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Countries

China (1)